Executive search firm Toft Group has placed Ms. Stacy Mecham as Vice President of Pharmaceutical Solutions at Navigating Cancer in Seattle, WA.
Ms. Mecham is a strategic business development leader with 15 years of pharmaceutical market research experience, primarily focused on oncology. She joined AlphaImpactRx prior to its acquisition by IQVIA/QuintilesIMS as Senior Vice President of the oncology franchise. Ms. Mecham previously served with Bristol-Myers Squibb as the Associate Director, Oncology Customer Insights. Prior to BMS Ms. Mecham was Vice President of oncology franchise for ImpactRx. Earlier in her industry career, Ms. Mecham held roles in market research and business development for Verispan, LLC.
Ms. Mecham has a M.Ed in counseling psychology from Temple University and a BA in psychology from West Chester University of Pennsylvania.
About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.
About Navigating Cancer
Navigating Cancer was founded in 2008 as the result of two healthcare and technology veterans coming together to fill a critical gap in oncology care: a better patient experience. Driven by a shared passion to leverage technology in the healthcare space, the co-founders set out to create the first patient-centered platform for oncology. Today, the Navigating Care platform supports over one million patients and thousands of cancer care providers nationwide to lower costs, improve patient satisfaction and drive better outcomes.